Paul Pfeffer
Overview
Explore the profile of Paul Pfeffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevenson F, Pfeffer P, Walker S, Ismaila H, Jegatheesan V, Mohammad I, et al.
BMJ Open
. 2024 Nov;
14(11):e092824.
PMID: 39609032
Objectives: The potential and expected benefits of digital health interventions (DHI) have long been discussed, yet substantial challenges are associated with deploying DHI at scale. Insights are presented concerning the...
2.
Wang J, Goodfellow H, Walker S, Blandford A, Pfeffer P, Hurst J, et al.
BMJ Open
. 2024 Nov;
14(11):e088538.
PMID: 39537389
Objectives: To examine trajectories of functional limitations, fatigue, health-related quality of life (HRQL) and societal costs of patients referred to long COVID clinics. Design: A population-based longitudinal cohort study using...
3.
Le T, Price D, Erhard C, Cook B, Quinton A, Katial R, et al.
J Asthma Allergy
. 2024 Oct;
17:1055-1069.
PMID: 39479509
Introduction: Patients with severe asthma may be prescribed biologic therapies to improve disease control. The EVEREST study aimed to characterize the global disease burden of patients with severe asthma without...
4.
Elneima O, McAuley H, Leavy O, Chalmers J, Horsley A, Ho L, et al.
Int J Epidemiol
. 2024 Oct;
53(1).
PMID: 39429158
No abstract available.
5.
Leavy O, Russell R, Harrison E, Lone N, Kerr S, Docherty A, et al.
ERJ Open Res
. 2024 Oct;
10(5).
PMID: 39351379
Background: In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown. We hypothesised that systemic corticosteroid administration during...
6.
McDowell R, Heaney L, Brown T, Bunting B, Burhan H, Chaudhuri R, et al.
PLoS One
. 2023 Dec;
18(12):e0295493.
PMID: 38060586
Background: The Asthma Control Questionnaire (ACQ) is used to assess asthma symptom control. The relationship between the questionnaire items and symptom control has not been fully studied in severe asthmatic...
7.
Scelo G, Torres-Duque C, Maspero J, Tran T, Murray R, Martin N, et al.
Ann Allergy Asthma Immunol
. 2023 Aug;
132(1):42-53.
PMID: 37640263
Background: Investigation for the presence of asthma comorbidities is recommended by the Global Initiative for Asthma because their presence can complicate asthma management. Objective: To understand the prevalence and pattern...
8.
Skene I, Kinley E, Pike K, Griffiths C, Pfeffer P, Steed L
BMJ Open
. 2023 Aug;
13(8):e069208.
PMID: 37550032
Objectives: The emergency department (ED) represents a place and moment of opportunity to provide interventions to improve long-term asthma outcomes, but feasibility, effectiveness and mechanisms of impact are poorly understood....
9.
Walker S, Goodfellow H, Pookarnjanamorakot P, Murray E, Bindman J, Blandford A, et al.
BMJ Open
. 2023 Jun;
13(6):e069217.
PMID: 37286327
Objectives: To describe self-reported characteristics and symptoms of treatment-seeking patients with post-COVID-19 syndrome (PCS). To assess the impact of symptoms on health-related quality of life (HRQoL) and patients' ability to...
10.
Pfeffer P, Hajmohammadi H, Cole J, Griffiths C, Hull S, De Simoni A
BJGP Open
. 2023 Mar;
7(2).
PMID: 36921995
Background: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma. However, in the authors' recent publication only a minority of patients...